CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in ALKS — Alkermes plc.

CIK 884546 SAN FRANCISCO, CA

Back to ALKS Full portfolio

Position in ALKS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$79,091,692

+$18,857,580 QoQ

Shares Held

2,236,756

+3.9% QoQ

Ownership

1.34%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

24 quarters on record

Voting authority Sole 99.99213146181344.ToString("F0")% Shared 0.ToString("F0")% None 0.00786853818655231.ToString("F0")%

Common Shares in ALKS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,628,257,886 across 43 Drug Manufacturers - Specialty & Generic names. ALKS ranks #6 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	3,717,247	$439,415,767
2	VTRS	Viatris Inc	13,674,306	$184,739,874
3	UTHR	UNITED THERAPEUTICS Corp	300,481	$178,179,223
4	NBIX	Neurocrine Biosciences Inc	902,788	$118,933,291
5	ELAN	Elanco Animal Health Inc	3,577,850	$85,617,950
6	ALKS	Alkermes plc. This page	2,236,756	$79,091,692
7	TEVA	Teva Pharmaceutical Industries Ltd	2,087,679	$62,880,891
8	LNTH	Lantheus Holdings, Inc.	657,413	$49,864,776

All Filings in ALKS

Export CSV

24 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$79,091,692	2,236,756	+3.9%	Shares	Sole	2026-05-15
2025-12-31	$60,234,112	2,152,756	+0.6%	Shares	Sole	2026-02-13
2025-09-30	$64,211,190	2,140,373	+2.3%	Shares	Sole	2025-11-10
2025-06-30	$59,853,521	2,092,049	+2.2%	Shares	Sole	2025-08-12
2025-03-31	$67,605,247	2,047,403	-1.0%	Shares	Sole	2025-09-15
2024-12-31	$59,503,318	2,068,961	-1.8%	Shares	Sole	2025-02-06
2024-09-30	$58,976,301	2,107,049	-11.6%	Shares	Sole	2024-11-12
2024-06-30	$57,419,864	2,382,567	+2.0%	Shares	Sole	2024-08-12
2024-03-31	$63,260,018	2,336,905	+8.8%	Shares	Sole	2024-05-09
2023-12-31	$59,561,164	2,147,122	-0.7%	Shares	Sole	2024-02-06
2023-09-30	$60,563,165	2,162,198	+5.6%	Shares	Sole	2023-11-08
2023-06-30	$64,096,453	2,047,810	+5.1%	Shares	Sole	2023-08-10
2023-03-31	$54,937,038	1,948,813	-1.1%	Shares	Sole	2023-05-12
2022-12-31	$51,502,308	1,971,003	+2.4%	Shares	Sole	2023-02-13
2022-09-30	$42,969,507	1,924,295	+2.6%	Shares	Sole	2022-11-14
2022-06-30	$55,858,901	1,875,089	-2.8%	Shares	Sole	2022-08-15
2022-03-31	$50,762,856	1,929,413	+3.0%	Shares	Sole	2022-05-13
2021-12-31	$43,571,213	1,873,225	-3.2%	Shares	Sole	2022-02-11
2021-09-30	$59,665,500	1,934,679	+21.4%	Shares	Sole	2021-11-16
2021-06-30	$39,065,631	1,593,215	+30.8%	Shares	Sole	2021-08-16
2021-03-31	$22,747,775	1,217,761	+2.7%	Shares	Sole	2021-05-17
2020-12-31	$23,661,657	1,186,048	+0.5%	Shares	Sole	2021-02-16
2020-06-30	$22,899,025	1,179,754	+2.9%	Shares	Sole	2020-08-20
2020-03-31	$16,528,766	1,146,239	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.